Artelo Biosciences Inc (ARTL)
1.36
+0.04
(+3.02%)
USD |
NASDAQ |
May 16, 16:00
1.32
-0.04
(-2.94%)
After-Hours: 20:00
Artelo Biosciences Shareholders Equity (Quarterly): 9.537M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.537M |
| December 31, 2023 | 11.75M |
| September 30, 2023 | 14.58M |
| June 30, 2023 | 16.27M |
| March 31, 2023 | 17.64M |
| December 31, 2022 | 19.40M |
| September 30, 2022 | 21.90M |
| June 30, 2022 | 23.84M |
| March 31, 2022 | 25.78M |
| December 31, 2021 | 27.17M |
| November 30, 2021 | 28.29M |
| August 31, 2021 | 12.04M |
| May 31, 2021 | 11.92M |
| February 28, 2021 | 12.86M |
| November 30, 2020 | 9.054M |
| August 31, 2020 | 3.875M |
| May 31, 2020 | 3.225M |
| February 29, 2020 | 3.708M |
| November 30, 2019 | 4.963M |
| August 31, 2019 | 5.461M |
| Date | Value |
|---|---|
| May 31, 2019 | 0.1344M |
| February 28, 2019 | -0.6922M |
| November 30, 2018 | -0.4752M |
| August 31, 2018 | -0.135M |
| May 31, 2018 | -0.0913M |
| February 28, 2018 | 0.3853M |
| November 30, 2017 | 0.294M |
| August 31, 2017 | 0.5448M |
| May 31, 2017 | -0.1139M |
| February 28, 2017 | -0.0195M |
| November 30, 2016 | -0.0065M |
| August 31, 2016 | -0.0138M |
| May 31, 2016 | -0.0095M |
| February 29, 2016 | -0.0044M |
| November 30, 2015 | 0.0007M |
| August 31, 2015 | 0.0153M |
| May 31, 2015 | 0.0126M |
| February 28, 2015 | 0.0066M |
| August 31, 2014 | 0.0147M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.1344M
Minimum
May 2019
28.29M
Maximum
Nov 2021
13.49M
Average
12.04M
Median
Aug 2021
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 70.02B |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.35M |
| Total Liabilities (Quarterly) | 0.817M |